Data-Driven Drug Discovery and Molecular Informatics

Publications

Tips on using this search form

  • All search terms are case-insensitive
  • If you specify more than one search option (e.g. you search for both "Authors" and "Paper title") then the publications returned will be those that match all of your search terms
  • To reset the search form, click here
  • Currently displaying 441 - 460 of 562 publications
Author(s)
Publication title
Journal Name
Publication year
The NRF2‐related interactome and regulome contain multifunctional proteins and fine‐tuned autoregulatory loops
D Papp, K Lenti, D Módos, D Fazekas, Z Dúl, D Türei, L Földvári-Nagy, R Nussinov, P Csermely, T Korcsmáros
FEBS Lett
(2012)
586
(doi: 10.1016/j.febslet.2012.05.016)
A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design.
MPA Sanders, L Roumen, E van der Horst, JR Lane, HF Vischer, J van Offenbeek, H de Vries, S Verhoeven, KY Chow, F Verkaar, MW Beukers, R McGuire, R Leurs, AP Ijzerman, J de Vlieg, IJP de Esch, GJR Zaman, JPG Klomp, A Bender, C de Graaf
J Med Chem
(2012)
55
(doi: 10.1021/jm300280e)
Recognizing pitfalls in virtual screening: a critical review.
T Scior, A Bender, G Tresadern, JL Medina-Franco, K Martínez-Mayorga, T Langer, K Cuanalo-Contreras, DK Agrafiotis
J Chem Inf Model
(2012)
52
(doi: 10.1021/ci200528d)
Computational prediction of metabolism: Sites, products, SAR, P450 enzyme dynamics, and mechanisms
J Kirchmair, MJ Williamson, JD Tyzack, L Tan, PJ Bond, A Bender, RC Glen
Journal of Chemical Information and Modeling
(2012)
52
(doi: 10.1021/ci200542m)
Discovery of potent and selective adenosine receptor ligands via multi-objective design
D Rodriguez, E Sotelo, H Gutierrez-de-Teran, A Bender
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
(2012)
243
Discovery, design and synthesis of a novel series of non-peptidomimetic inhibitors of XIAP-caspase 9 interactions
DM Allwood, RM Myers, F Richards, A Bender, C Watts, SV Ley
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
(2012)
243
The challenges involved in modeling toxicity data in silico: a review.
MP Gleeson, S Modi, A Bender, RL Marchese Robinson, J Kirchmair, M Promkatkaew, S Hannongbua, RC Glen
Current Pharmaceutical Design
(2012)
18
(doi: 10.2174/138161212799436359)
Diversity-oriented synthesis
WRJD Galloway, RJ Spandl, A Bender, GL Thomas, M Diaz-Gavilan, KMG O’Connell, DR Spring
(2012)
(doi: 10.1017/CBO9781139021500.007)
A-Ring Dihalogenation Increases the Cellular Activity of Combretastatin-Templated Tetrazoles
TM Beale, DM Allwood, A Bender, PJ Bond, JD Brenton, DS Charnock-Jones, SV Ley, RM Myers, JW Shearman, J Temple, J Unger, CA Watts, J Xian
ACS Med Chem Lett
(2012)
3
(doi: 10.1021/ml200149g)
canSAR: An integrated cancer public translational research and drug discovery resource
MD Halling-Brown, KC Bulusu, M Patel, JE Tym, B Al-Lazikani
Nucleic Acids Research
(2012)
40
(doi: 10.1093/nar/gkr881)
Virtual Screening Data Fusion Using Both Structure- and Ligand-Based Methods
F Svensson, A Karlén, C Sköld
J Chem Inf Model
(2011)
52
(doi: 10.1021/ci2004835)
Understanding and Classifying Metabolite Space and Metabolite-Likeness
JE Peironcely, T Reijmers, L Coulier, A Bender, T Hankemeier
PLoS ONE
(2011)
6
(doi: 10.1371/journal.pone.0028966)
Which compound to select in lead optimization? Prospectively validated proteochemometric models guide preclinical development.
GJP van Westen, JK Wegner, P Geluykens, L Kwanten, I Vereycken, A Peeters, AP Ijzerman, HWT van Vlijmen, A Bender
PLoS ONE
(2011)
6
(doi: 10.1371/journal.pone.0027518)
From in silico target prediction to multi-target drug design: Current databases, methods and applications
A Koutsoukas, B Simms, J Kirchmair, PJ Bond, AV Whitmore, S Zimmer, MP Young, JL Jenkins, M Glick, RC Glen, A Bender
Journal of Proteomics
(2011)
74
(doi: 10.1016/j.jprot.2011.05.011)
Computational Approaches in Cheminformatics and Bioinformatics
R Guha, A Bender
Computational Approaches in Cheminformatics and Bioinformatics
(2011)
(doi: 10.1002/9781118131411)
Bridging Chemical and Biological Data: Implications for Pharmaceutical Drug Discovery
JL Jenkins, J Scheiber, D Mikhailov, A Bender, A Schuffenhauer, B Cornett, V Chan, J Kondracki, B Rohde, JW Davies
(2011)
(doi: 10.1002/9781118131411.ch2)
Substructure‐Based Virtual Screening for Adenosine A2A Receptor Ligands
E van der Horst, R van der Pijl, T Mulder-Krieger, A Bender, AP Ijzerman
ChemMedChem
(2011)
6
(doi: 10.1002/cmdc.201100369)
Libraries from Libraries: Comprehensive characterization of molecular diversity of bis-diazacyclic libraries
F Lopez-Vallejo, A Nefzi, A Bender, JR Owen, IT Nabney, RA Houghten, JL Medina-Franco
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
(2011)
242
Chemogenomics Approaches for Receptor Deorphanization and Extensions of the Chemogenomics Concept to Phenotypic Space
E van der Horst, JE Peironcely, GJP van Westen, OO van den Hoven, WRJD Galloway, DR Spring, JK Wegner, HWT van Vlijmen, AP Ijzerman, JP Overington, A Bender
Current topics in medicinal chemistry
(2011)
11
(doi: 10.2174/156802611796391230)
Ask the experts: focus on computational chemistry.
J Bajorath, ML Barreca, A Bender, R Bryce, M Hutter, C Laggner, C Laughton, Y Martin, J Mitchell, A Padova, S Renner, PM Selzer, W Sherman, W Sippl, C Taft, T Tuccinardi, G Vistoli, P Willett
Future Med Chem
(2011)
3
(doi: 10.4155/fmc.11.57)
Yusuf Hamied Department of Chemistry
Lensfield Road
Cambridge
CB2 1EW
T: +44 (0) 1223 336300
enquiries@ch.cam.ac.uk
Contacts
Directions

Privacy and cookie policy

About the Department

Departmental Services

Bender Group

Email: ab454@cam.ac.uk
T: 01223 762983

Study at Cambridge

About the University

Research at Cambridge